Robust Demand Across BioPharma and NGS Applications Elevates Twist Bioscience Corp.’s (TWST) Growth Profile

Conestoga Capital Advisors, an asset management company, released its third-quarter 2026 investor letter. The letter can be downloaded here. Conestoga Capital Advisors released its third-quarter 2026 investor letter, outlining a shifting macroeconomic backdrop for small-cap equities. After a strong start to 2026, 3Q26 headwinds—including elevated oil prices, persistent inflation, and a September Fed rate hike—drove a 9.4% quarterly drop in the Russell 2000 Growth Index (vs. +2.3% for...